Carl Dambkowski, Chief Medical Officer at Apogee Therapeutics, Inc. (APGE), sold 5,260 shares at $37.82 ($199K) on 2025-09-03, disclosed to the SEC on 2025-09-05.
Scheduled sale ($199k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.82 | 2,535 | $96K | 48.2% |
| 2 | $37.82 | 2,535 | $96K | 48.2% |
| 3 | $38.55 | 190 | $7K | 3.7% |
| Total | $37.85 avg | 5,260 | $199K | 100% |
| Filing → |
| ORKA | SELL | 2026-06-12 | $2.5M | — | Filing → |
| APGE | SELL | 2026-06-05 | $433K | — | Filing → |
| ORKA | SELL | 2026-05-22 | $6.2M | — | Filing → |